A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.
Insulin sensitivity is how responsive cells are to insulin, an essential hormone that controls blood glucose levels. An increase in insulin sensitivity means insulin can more effectively lower the blood glucose. Reduced insulin sensitivity or insulin resistance is a feature of Type 2 diabetes. Thus, improved insulin sensitivity can reduce the risk of developing Type 2 diabetes or improve its treatment.
GLP-1R agonists are medications that influence metabolism, such as decreasing blood sugar levels by promoting insulin secretion. Dipeptidyl peptidase 4 (DPP-4) inhibitors block the degradation of the body’s own endogenous GLP-1, as well as other peptide hormones such as glucose-dependent insulinotropic peptide (GIP).
“We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on insulin sensitivity, independent from weight loss,” said Mona Mashayekhi MD, PhD, assistant professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism. “This effect requires activation of the GLP-1 receptor, but increasing the body’s own endogenous GLP-1 through the use of the DPP4 inhibitor sitagliptin does not achieve similar effects.”
“Our research suggests that liraglutide, and presumably other GLP-1R agonists, are having important metabolic effects in a way that’s different from increasing endogenous GLP-1 levels, even though they’re using the same receptor. Future research will focus on potential mechanisms of how GLP-1R agonists are improving insulin sensitivity independent of weight loss.”
Eighty-eight individuals with obesity and pre-diabetes were randomized for 14 weeks to receive the GLP-1R agonist liraglutide, the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin, or weight loss without drug using a low-calorie diet.
To further investigate the GLP-1R-dependent effects of the treatments, the GLP-1R antagonist exendin and a placebo were given in a two-by-two crossover study during mixed meal tests. Crossover studies allow the response of a subject to treatment A to be compared with the same subject’s response to treatment B.
Liraglutide was shown to rapidly improve insulin sensitivity as well as decrease blood glucose within two weeks of beginning treatment and before any weight loss.
“GLP-1R agonists are an exciting class of medications, given their strong glucose-lowering effects combined with tremendous weight-loss benefits, and they have transformed how we manage diabetes and obesity in the clinic,” Mashayekhi said. “Since the number of medications in this class is rapidly expanding, a deeper understanding of the mechanisms of benefit is crucial so we can design the right drugs for the desired effects in the right patients.”
The investigators’ prior research demonstrated that liraglutide, but not sitagliptin or diet, improves measures of heart disease and inflammation. This matches the clinical findings of reduced cardiovascular disease with GLP-1R agonist treatment.
Future studies will continue to explore both receptor- and weight loss-dependent effects of GLP-1R agonists in humans.
This research was supported by the American Heart Association (17SFRN33520017), National Center for Advancing Translational Sciences (5UL1TR002243), and the National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007061) This work utilized the cores of the Vanderbilt Diabetes Research and Training Center funded by grant DK020593 from the National Institute of Diabetes and Digestive and Kidney Disease. Novo Nordisk provided liraglutide and matching placebo.
END
Study shows liraglutide results in increased insulin sensitivity independent of weight loss
2024-01-04
(Press-News.org)
ELSE PRESS RELEASES FROM THIS DATE:
YAP and TAZ: Protein partners identified as potential key for fetal bone development
2024-01-04
A pair of proteins, YAP and TAZ, has been identified as conductors of bone development in the womb and could provide insight into genetic diseases such as osteogenesis imperfecta, known commonly as “brittle bone disease.” This small animal-based research, published today in Developmental Cell and led by members of the McKay Orthopaedic Research Laboratory of the Perelman School of Medicine at the University of Pennsylvania, adds understanding to the field of mechanobiology, which studies how mechanical forces influence biology.
“Despite more than a century of study on the mechanobiology of bone development, the cellular and molecular ...
Skin-deep resilience: Hidden physical health costs for minority youth overcoming adversity
2024-01-04
Urbana, Ill. – When youth thrive despite difficult circumstances, they are usually lauded for their accomplishments. However, overcoming adversity may have a hidden physiological cost, especially for minority youth. A new study from the University of Illinois Urbana-Champaign looks at physiological changes among high-striving minority youth in early adolescence.
“In the past decade, researchers have observed a phenomenon termed ‘skin-deep resilience.’ Historically, youth from disadvantaged backgrounds who ‘beat the odds’ were assumed to have universally positive outcomes. They are achieving academically, avoiding problematic behaviors, and scoring well on ...
Early nerve intervention reduces pain and complications after amputation
2024-01-04
Waltham — January 4, 2024 — Performed early – at the time of amputation – a procedure called targeted muscle reinnervation (TMR) can reduce pain scores and prevent complications related to abnormal nerve regrowth, suggests a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Our experience suggests that that acute TMR reduces neuroma formation, and lowers the incidence of both phantom ...
Seizures identified as potential cause of sudden unexplained death in children
2024-01-04
In a study designed to better understand sudden, unexpected deaths in young children, which usually occur during sleep, researchers have identified brief seizures, accompanied by muscle convulsions, as a potential cause.
Experts estimate in excess of 3,000 families each year in the United States lose a baby or young child unexpectedly and without explanation. Most are infants in what is referred to as sudden infant death syndrome, or SIDS, but 400 or more cases involve children aged 1 and older, and in what is called sudden unexplained death in children (SUDC). Over half of these children are toddlers.
The study findings come from a registry of more than 300 SUDC cases, set up ...
Where’s the snow? Northeastern cities see record temps, low snowfall in 2023
2024-01-04
CORNELL UNIVERSITY MEDIA RELATIONS OFFICE
FOR RELEASE: Jan. 4, 2024
Kaitlyn Serrao
607-882-1140
kms465@cornell.edu
Where’s the snow? Northeastern cities see record temps, low snowfall in 2023
ITHACA, N.Y. - In the Northeastern United States, warming average temperatures for most all climate data sites in December 2023 ranged from 3.6 to 9 degrees Fahrenheit above normal – making 2023 the warmest year on record for 13 of the region’s 35 major locations, including New York City.
A total of 28 cities in the region saw one of their top-five warmest years, according to a report Jan. 2 ...
World's largest physics conference to be held in Minneapolis and online this March
2024-01-04
More than 13,000 physicists from around the world will convene to present groundbreaking research at the American Physical Society’s (APS) March Meeting. The conference will be held in person in Minneapolis and online everywhere March 3-8.
Scientific Program
The scientific program includes nearly 900 sessions and 11,000 individual presentations on new research in climate science, medicine, biological physics, quantum information, superconductivity, condensed matter, and more. For more information, search the scientific program. All times are in Central time.
Hybrid Format
The March Meeting will have both in-person and online experiences. ...
The (wrong) reason we keep secrets
2024-01-04
In and out of the workplace, people often keep adverse information about themselves secret because they worry that others will judge them harshly. But those fears are overblown, according to new research from the McCombs School of Business.
In fact, when study participants pushed through fear to reveal a secret, those in whom they confided were significantly more charitable than they expected.
“When we’re thinking about conveying negative information about ourselves, we’re focused on the content of the message,” said study co-author Amit Kumar, assistant professor of marketing at Texas McCombs. “But the ...
Variants in PPFIA3, a synaptic scaffolding protein, discovered to be the cause of a newly recognized syndromic neurodevelopmental disorder.
2024-01-04
An international collaborative study led by postdoctoral scientist, Dr. Maimuna Paul, and child neurologist, Dr. Hsiao-Tuan Chao, an assistant professor at Baylor College, a faculty member with the Cain Pediatric Neurology Research Foundation Laboratories at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, and an investigator at the McNair Medical Institute with The Robert and Janice McNair Foundation, recently discovered that variants in the PPFIA3 gene ...
Focused on author support and research integrity, Science journals adopt Proofig software
2024-01-04
As part of continued efforts to bolster the integrity of the scholarly record, the Science journals have partnered with Proofig AI image integrity software.
Adoption of Proofig AI positions authors to resolve image-related issues before a paper is published. It also ensures the highest standards of accuracy in work published in the six Science family journals.
“Rigorous data are a cornerstone of our publications,” said Valda Vinson, Executive Editor of Science. “Image manipulation and duplication ...
Lighting the circuits to risky decision-making
2024-01-04
Life consists of infinite possibilities — appearing in the real world as multiple choices, that then require decision-making in order to determine the best course of action. However, with every choice there also exists a certain amount of uncertainty or ‘risk’. Therefore, behind every decision, lies an intricate evaluation process that balances the ‘risks’ and ‘rewards’ associated with taking such actions. This can, in extreme cases, manifest itself as a pathological behavioral state of high risk-high return (HH) and low risk-low return (LL) decision processing that has been associated with gambling disorders.
Although ...